Published in Free Radic Res on August 01, 1995
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet (2000) 6.19
Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) (1975) 5.68
Parents as the exclusive agents of change in the treatment of childhood obesity. Am J Clin Nutr (1998) 2.49
Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation (2000) 2.32
Solubilization of phospholipids by detergents. Structural and kinetic aspects. Biochim Biophys Acta (1983) 2.05
Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia. J Lipid Res (1982) 1.57
States of aggregation and phase transformations in mixtures of phosphatidylcholine and octyl glucoside. Biochemistry (1990) 1.51
Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins. J Lipid Res (1978) 1.48
Characterization of the solubilization of lipid bilayers by surfactants. Biochim Biophys Acta (1985) 1.48
Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res (2004) 1.46
The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein. Biochim Biophys Acta (1975) 1.46
A clinical data repository enhances hospital infection control. Proc AMIA Annu Fall Symp (1997) 1.43
Solubilization of phosphatidylcholine bilayers by octyl glucoside. Biochemistry (1982) 1.34
Radioimmunoassay of arginine-rich apolipoprotein of rat serum. Biochim Biophys Acta (1977) 1.32
A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides. Am J Med (1981) 1.28
Role of behaviour modification in the treatment of childhood obesity with the parents as the exclusive agents of change. Int J Obes Relat Metab Disord (1998) 1.27
Liposomes: preparation, characterization, and preservation. Methods Biochem Anal (1988) 1.24
Visualization of virus-like particles in endoplasmic reticulum of hepatocytes of Australia antigen carriers. Lab Invest (1972) 1.23
Kinetic and structural aspects of reconstitution of phosphatidylcholine vesicles by dilution of phosphatidylcholine-sodium cholate mixed micelles. Biochemistry (1986) 1.13
Apoprotein content of plasma lipoproteins of the rat separated by gel chromatography or ultracentrifugation. Biochem Med (1977) 1.11
Radioimmunoassay of human high density lipoprotein apo-protein A-1. Biochim Biophys Acta (1975) 1.10
Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. J Clin Invest (1984) 1.10
Hydrolysis of dipalmitoylphosphatidylcholine large unilamellar vesicles by porcine pancreatic phospholipase A2. J Biol Chem (1986) 1.06
Structural and kinetic studies on the solubilization of lecithin by sodium deoxycholate. Biochemistry (1979) 1.05
The interpretation of proton magnetic resonance linewidths for lecithin dispersions. Effect of particle size and chain packing. Biochim Biophys Acta (1975) 1.05
Temporal arteritis in Israel. A review of 47 patients. J Rheumatol (1979) 1.04
Radioimmunoassay of apolipoprotein A-I of rat serum. Biochim Biophys Acta (1976) 1.04
Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. J Biol Chem (1989) 1.04
Hydrolysis of dipalmitoylphosphatidylcholine small unilamellar vesicles by porcine pancreatic phospholipase A2. J Biol Chem (1986) 1.04
Simplified surveillance for nosocomial bloodstream infections. Infect Control Hosp Epidemiol (1998) 1.03
Secretion of the arginine-rich and A-I apolipoproteins by the isolated perfused rat liver. J Lipid Res (1977) 1.02
Partitioning of octyl glucoside between octyl glucoside/phosphatidylcholine mixed aggregates and aqueous media as studied by isothermal titration calorimetry. Biophys J (1997) 1.01
Apoprotein synthesis by human duodenojejunal mucosa. Gastroenterology (1978) 1.01
Origin and transport of the A-I and arginine-rich apolipoproteins in mesenteric lymph of rats. J Lipid Res (1978) 0.98
Behçet's disease with decreased fibrinolysis and superior vena caval occlusion. Br Med J (1973) 0.96
Direct visualization of lipid aggregates in native human bile by light- and cryo-transmission electron-microscopy. FEBS Lett (1994) 0.95
Evaluation of antioxidants: scope, limitations and relevance of assays. Chem Phys Lipids (2012) 0.94
Vesicle- vesicle interactions in sonicated dispersions of dipalmitoylphosphatidylcholine. Biochemistry (1981) 0.94
Effect of surface curvature on stability, thermodynamic behavior, and osmotic activity of dipalmitoylphosphatidylcholine single lamellar vesicles. Biochemistry (1981) 0.94
Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis. Kidney Int (1999) 0.93
Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells. Rheumatology (Oxford) (2005) 0.93
A new method for preparation of phospholipid vesicles (liposomes) - French press. FEBS Lett (1979) 0.92
Evidence that a separate particle containing B-apoprotein is present in high-density lipoproteins from perfused rat liver. Metabolism (1977) 0.91
Inhibition of phospholipase A(2) as a therapeutic target. Biochim Biophys Acta (2000) 0.91
Hydrolysis of phosphatidylcholine in phosphatidylcholine-cholate mixtures by porcine pancreatic phospholipase A2. J Biol Chem (1988) 0.91
In vitro production of human plasma low density lipoprotein-like particles. A model for very low density lipoprotein catabolism. J Biol Chem (1979) 0.90
Hypolipidemic effect of beta, beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in normal and nephrotic rats. J Lipid Res (1988) 0.89
Lipid oxidation in unfractionated serum and plasma. Chem Phys Lipids (1998) 0.89
Insulin resistance in obesity: body-weight or energy balance? J Endocrinol (2001) 0.88
The use of commercially available lipid emulsions for the preparation of amphotericin B-lipid admixtures. J Antimicrob Chemother (1997) 0.88
Aggregation of phospholipid vesicles by water-soluble polymers. Biophys J (1996) 0.87
Physico-chemical characterization of Intralipid emulsions. Biochim Biophys Acta (1991) 0.87
Virus-like particles in cytoplasm of livers of Au-antigen carriers. Lancet (1971) 0.87
Increased catecholamine release from adrenal medulla by liposomes loaded with sodium or calcium ions. Biochem Pharmacol (1979) 0.86
Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol (1999) 0.86
Temperature-dependence of the solubilization of dipalmitoylphosphatidylcholine (DPPC) by the non-ionic surfactant Triton X-100, kinetic and structural aspects. Chem Phys Lipids (2003) 0.86
Impact of treatment for childhood obesity on parental risk factors for cardiovascular disease. Prev Med (1999) 0.86
Enteral administration of heparin. Thromb Res (1979) 0.86
Effect of weight loss in moderate obesity on plasma lipoprotein and apolipoprotein levels and on high density lipoprotein composition. Arteriosclerosis (1984) 0.86
Kinetic analysis of copper-induced peroxidation of LDL. Biochim Biophys Acta (1998) 0.85
Dependence of the conformation of the polar head groups of phosphatidylcholine on its packing in bilayers. Nuclear magnetic resonance studies on the effect of the binding of lanthanide ions. Biochemistry (1979) 0.85
Lipid infusion with different triglyceride cores (long-chain vs medium-chain/long-chain triglycerides): effect on plasma lipids and bilirubin binding in premature infants. JPEN J Parenter Enteral Nutr (1992) 0.84
Transport of vitamin D sterols in human plasma: effect of excess vitamin D, 25 hydroxyvitamin D and 1,25 dihydroxyvitamin D. Eur J Clin Invest (1979) 0.83
Intestinal absorption of vitamin D sterols: differential absorption into lymph and portal blood in the rat. Gastroenterology (1981) 0.83
The heat of transfer of lipid and surfactant from vesicles into micelles in mixtures of phospholipid and surfactant. Biophys J (1997) 0.83
Thermodynamic characterization of the pretransition of unilamellar dipalmitoyl-phosphatidylcholine vesicles. Lipids (1984) 0.83
Copper-induced peroxidation of phosphatidylserine-containing liposomes is inhibited by nanomolar concentrations of specific antioxidants. Chem Phys Lipids (2007) 0.82
Relationship between the activity of pancreatic phospholipase A2 and the physical state of the phospholipid substrate. J Biol Chem (1981) 0.82
The effect of cholesterol on the solubilization of phosphatidylcholine bilayers by the non-ionic surfactant Triton X-100. Chem Phys Lipids (2005) 0.82
Defibrination following Echis colorata bite in man. Isr J Med Sci (1971) 0.81
Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patients. Am J Kidney Dis (1999) 0.81
Regulation of lipoprotein lipase secretion in murine macrophages during foam cell formation in vitro. Effect of triglyceride-rich lipoproteins. Arterioscler Thromb (1992) 0.81
The role of lysophosphatidylcholine and apolipoprotein A in the cholesterol-removing capacity of lipoprotein-deficient serum in tissue culture. Biochim Biophys Acta (1979) 0.81
Kinetics of peritoneal protein loss during CAPD: II. Lipoprotein leakage and its impact on plasma lipid levels. Kidney Int (1990) 0.81
Apolipoprotein A-I synthesis and secretion by cultured human intestinal mucosa. Metabolism (1979) 0.81
Kinetic analysis of copper-induced peroxidation of HDL, autoaccelerated and tocopherol-mediated peroxidation. Free Radic Biol Med (2000) 0.81
Inner ear involvement in Behçet's disease. Arch Otolaryngol (1980) 0.80
Effect of water-soluble polymers on the state of aggregation, vesicle size, and phase transformations in mixtures of phosphatidylcholine and sodium cholate. Biophys J (1996) 0.80
Apolipoprotein B exhibits phospholipase A1 and phospholipase A2 activities. FEBS Lett (1993) 0.80
Structural characteristics of phospholipid multilamellar liposomes. J Pharm Sci (1984) 0.80
Single-stage evaluation of serum lipoproteins by gel permeation using a specific fluorescent lipid probe. J Chromatogr (1987) 0.80
Interaction of hyaluronic acid-linked phosphatidylethanolamine (HyPE) with LDL and its effect on the susceptibility of LDL lipids to oxidation. Chem Phys Lipids (2000) 0.79
Studies on the molecular packing of mixed dispersions of Triton X-100 and sphingomyelin and its dependence on temperature and cloud point. Biochemistry (1979) 0.79
Aggregation of plasma lipids and lipoproteins in families with and without coronary heart disease. Atherosclerosis (1985) 0.79
Effect of sperm preparation with TEST yolk buffer on sperm-binding capacity under hemizona assay conditions. Andrologia (1997) 0.79
Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance. Biochem Biophys Res Commun (1995) 0.79
The effect of egg yolk on the binding capacity of human spermatozoa to zona pellucida. Fertil Steril (1994) 0.79
Does lipid infusion affect bile composition in humans? Isr J Med Sci (1996) 0.78
Calcium binding to bile salts. Chem Phys Lipids (1991) 0.78
Effect of a short-term graded exhaustive exercise on the susceptibility of serum lipids to oxidation. Int J Sports Med (2005) 0.78
Oxidation of fluorescent glycero- and sphingophospholipids in human plasma lipoproteins: alkenylacyl subclasses are preferred targets. Clin Biochem (1996) 0.78
Cholesterol precipitation from cholesterol-supersaturated bile models. Biochim Biophys Acta (1995) 0.78
Effect of calcium on kinetic and structural aspects of dilution-induced micellar to lamellar phase transformation in phosphatidylcholine-cholate mixtures. Biochemistry (1988) 0.78
Apolipoproteins in human fetal blood and amniotic fluid in mid-trimester pregnancy. Prenat Diagn (1981) 0.78
Optic nerve regeneration in adult fish and apolipoprotein A-I. J Neurochem (1989) 0.78
Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia. Eur J Clin Invest (1986) 0.78
Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteins. Kidney Int (1990) 0.78